TGFB1 and central nervous system cancer: Several approaches evaluated the inhibition of TGF-β signaling in glioma (www.clinicaltrials.gov) using antibodies, antisense oligonucleotides, ligand traps or TGF-β receptor kinase inhibitors29,45.